Advanced Enzyme Technologies Limited – A Rising Global Star
9
Manufacturing Units
India - 7 USA - 2
Manufacturing Units
India - 7 USA - 2
7
R&D Units
India – 5 | USA – 1 | Germany –1
R&D Units
India – 5 | USA – 1 | Germany –1
68+
Enzymes & Probiotics
Enzymes & Probiotics
400+
Proprietary Products
Proprietary Products
700+
Customers Worldwide
Customers Worldwide
45+
Countries
Worldwide Presence
Countries
Worldwide Presence
750+
Employees
Employees
13*
Patents
Patents
12#
Food Enzyme Dossiers filed with EFSA
Food Enzyme Dossiers filed with EFSA
5**
GRAS Dossier
evaluated by US FDA
GRAS Dossier
evaluated by US FDA
5000
m3 Fermentation Capacity
m3 Fermentation Capacity
25+
Years of Fermentation Experience
Years of Fermentation Experience
Note:
* Patents includes the filed applications
# Food Dossier filed with EFSA, out of which positive R&D Units opinion is received for 4 Dossiers & 8 are under evaluation
** No question letter received for 4 Dossier, another 1 is under evaluation
Revenue from Operations
EBIDTA & EBIDTA Margin (%)
PAT & PAT Margin (%)
Net Worth (₹ mn)
ROE (%) & ROCE (%)
Brief History and Evolution
1985
Cal-India Foods International is founded by Mr. V.L. Rathi
1989
Advanced Biochemicals Pvt Ltd. Is incorporated
1994
Started fermentation facility at Sinnar, Maharashtra
2001
R&D centres (Thane and Sinnar) recognized by DSIR
2005
Advanced Biochemicals Ltd. is renamed as Advanced Enzyme Technologies Limited (or Advanced Enzymes)
2011
Takeover of Cal-India Foods International –USA presence
2012
- Equity investment by Kotak Private Equity
- Takeover of Advance Supplementary Technologies
- 2nd fermentation facility commissioned at Pithampur, Indore
2016
- Floated IPO
- Acquired 70% stake in JC Biotech with a fermentation facility at Ongole, Andhra Pradesh
2017
- Acquired 100% stake in evoxx technologies GmbH, Germany
- 1st GRAS dossier was filed with USFDA
2018
- 4 food enzymes got approved as a processing aid with Food Safety Standard Authority of India (FSSAI)
- 4 enzymes are registered with REACH -ECHA (European Chemical Agency)
2021
Acquired 51% stake in SciTech Specialities with 2 manufacturing facilities and 1 R&D unit
20212
- Received NIH grant for ImmunoSEB and ProbioSEB CSC3)
- Approvals of 2 GRAS Dossiers for SEBtilis™ and SEBclausii™
- Increased 15% stake in JC Biotech